Skip to content

Menu

Search

HOME
WHO ARE WE
WHAT WE DO
CINN IN PROGRESS
- Projects
- Publications
- Blogs
- News
MUSEUM “3D WORLD”
KNOWLEDGE DATABASE
CONTACT US
English
- English
- Español
Extranet

Close Menu

DNA methylation

IJC

29 January 2020

Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis

Publications 5-hydroxymethylcytosine, DNA methylation, Epigenetics, glioma, methylation arrays, Nanomedicine, TET3;

30 July 2019

Epigenetics

aging, cancer, DNA methylation, Epigenetics, histones, Nanomaterials

diagnostico cancer tiroides

18 September 2018

Improvement of the diagnostic yield of Fine Needle Aspiration Citology (FNAC) samples by detection of DNA methylation markers, and its application for the early diagnosis of Follicular Thyroid Carcinoma

Projects AECC, DNA methylation, Epigenetics and Nanomedicine, Thyroid Carcinoma

WHO ARE WE

> Overview
> Facts & figure
> Our industrial partners
> Team

WHAT WE DO

> Modelling and simulation
> Nanostructured hybrid systems
> Synthesis of nanocomposites and bioinspired materials
> Nanomedicine

APPLICATION FIELDS

Epigenetics
Inorganic antimicrobials
Periodontal and Peri Implant Diseases
Bone Grafts
Dental cad-cam materials

BIG SCIENCE

> Heat sinks
> Ir windows

ADVANCED MATERIALS

> Nanocomposite Powders
> EDM Ceramic
> Ultrastable ceramics
> Ultrahard metal-ceramic composites
> Graphene

> Quantum electronics
> Information storage
> Functional ceramics

SCIENTIFIC & TECHNICAL SERVICES

Nanotechnology Unit
Services

Biocompatibility Studies
Electromagnetic Characterization
Innovation
Mechanical Characterization
Microbiological Studies
Samples Preparation
Thermal Treatments and Sintering

COMMUNICATION & OUTREACH

CINN IN PROGRESS

> Projects
> Publications
> Blogs
> News

KNOWLEDGE DATABASE

> Institutional/Corporate info
> Heritage
> Health
> Advanced materials
> TIC
> Big science

LEGAL ADVICE | COOKIES

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok